Quoin Pharmaceuticals Ltd.
5 private offerings reported to the SEC on Form D since 2016, $163.8M sold in all. Pharma, VA.
- Form D offerings: 5
- Reported sold: $163.8M
- Newest: Sep 10, 2026
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Sep 10, 2026 | $50.0M | $50.0M | Quoin Pharmaceuticals Ltd.Pharma · VA | Not amended | 0001104659-26-106751 |
| Oct 23, 2025 | $105.3M | $105.3M | Quoin Pharmaceuticals, Ltd.Pharma · VA | Not amended | 0001104659-25-101869 |
| Aug 31, 2022 | $194K | $194K | Quoin Pharmaceuticals, Ltd.Pharma · Israel | Not amended | 0001458511-22-000001 |
| Feb 9, 2018 | $4.0M | $4.0M | Cellect Biotechnology Ltd.Pharma · Israel | Not amended | 0001213900-18-001471 |
| Sep 19, 2017 | $4.3M | $4.3M | Cellect Biotechnology Ltd.Pharma · Israel | Not amended | 0001213900-17-009834 |
SEC Profile
From the company's EDGAR record- Ticker
- QNRX
- Business address
- Ashburn, Va
- Incorporated in
- Israel
- SEC industry
- Pharmaceutical Preparations
- Former names
- Quoin Pharmaceuticals, Ltd.; Cellect Biotechnology Ltd.; Cellect Biomed Ltd.
- All SEC filings
- CIK 1671502 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR